{"id":"https://openalex.org/W2550109795","doi":"https://doi.org/10.1182/blood.v104.11.1802.1802","title":"A Phase I/II Study of Intravenous LBH589, a Novel Histone Deacetylase (HDAC) Inhibitor, in Patients (pts) with Advanced Hematologic Malignancies.","display_name":"A Phase I/II Study of Intravenous LBH589, a Novel Histone Deacetylase (HDAC) Inhibitor, in Patients (pts) with Advanced Hematologic Malignancies.","publication_year":2004,"publication_date":"2004-11-16","ids":{"openalex":"https://openalex.org/W2550109795","doi":"https://doi.org/10.1182/blood.v104.11.1802.1802","mag":"2550109795"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v104.11.1802.1802","doi":"https://doi.org/10.1182/blood.v104.11.1802.1802","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.1802.1802","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5061285204","display_name":"Francis Joseph Giles","orcid":"https://orcid.org/0000-0002-6919-0231","observed_orcids":["https://orcid.org/0000-0002-6919-0231"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francis J. Giles","raw_affiliation_strings":["Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058914292","display_name":"Thomas H. Fischer","orcid":"https://orcid.org/0000-0001-6118-5182","observed_orcids":["https://orcid.org/0000-0001-6118-5182"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Thomas Fischer","raw_affiliation_strings":["Johannes-Gutenberg-Universtat, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes-Gutenberg-Universtat, Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015101485","display_name":"J\u00f6rge E. Cortes","orcid":"https://orcid.org/0000-0002-8636-1071","observed_orcids":["https://orcid.org/0000-0002-8636-1071"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jorge Cortes","raw_affiliation_strings":["Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065211401","display_name":"James D. Beck","orcid":"https://orcid.org/0000-0001-5415-8311","observed_orcids":["https://orcid.org/0000-0001-5415-8311"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"James Beck","raw_affiliation_strings":["Johannes-Gutenberg-Universtat, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Johannes-Gutenberg-Universtat, Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045902951","display_name":"Farhad Ravandi\u2010Kashani","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Farhad Ravandi-Kashani","raw_affiliation_strings":["Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061026876","display_name":"Guillermo Garcia\u2010Manero","orcid":"https://orcid.org/0000-0002-3631-2482","observed_orcids":["https://orcid.org/0000-0002-3631-2482"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Guillermo Garcia-Manero","raw_affiliation_strings":["Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, UT MD Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044120213","display_name":"Bin Peng","orcid":"https://orcid.org/0000-0002-7860-3923","observed_orcids":["https://orcid.org/0000-0002-7860-3923"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Bin Peng","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036555074","display_name":"P. Rae","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Patricia E. Rae","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011708309","display_name":"Glen Laird","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Glen Laird","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088630606","display_name":"Samil Sharma","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Samil Sharma","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010851480","display_name":"Margaret Han Dugan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Margaret Dugan","raw_affiliation_strings":["Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027800341","display_name":"Maher X. Albitar","orcid":"https://orcid.org/0000-0002-0050-2030","observed_orcids":["https://orcid.org/0000-0002-0050-2030","https://orcid.org/0000-0001-7661-9537"]},"institutions":[{"id":"https://openalex.org/I74614422","display_name":"Quest Diagnostics (United States)","ror":"https://ror.org/010g9bb70","country_code":"US","type":"company","lineage":["https://openalex.org/I74614422"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Maher Albitar","raw_affiliation_strings":["Quest Diagnostic, Nichols Institute, San Juan Capistrano, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Diagnostic, Nichols Institute, San Juan Capistrano, CA, USA","institution_ids":["https://openalex.org/I74614422"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079069209","display_name":"Kapil N. Bhalla","orcid":"https://orcid.org/0000-0001-5209-5126","observed_orcids":["https://orcid.org/0000-0001-5209-5126"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kapil M. Bhalla","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL, USA","institution_ids":["https://openalex.org/I3019308854"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5010851480","https://openalex.org/A5011708309","https://openalex.org/A5036555074","https://openalex.org/A5044120213","https://openalex.org/A5045902951","https://openalex.org/A5088630606"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.5916,"has_fulltext":false,"cited_by_count":5,"citation_normalized_percentile":{"value":0.63707269,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"104","issue":"11","first_page":"1802","last_page":"1802"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11736","display_name":"Histone Deacetylase Inhibitors Research","score":0.9839000105857849,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10309","display_name":"Acute Myeloid Leukemia Research","score":0.014600000344216824,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11559","display_name":"Retinoids in leukemia and cellular processes","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/panobinostat","display_name":"panobinostat","score":0.9879999756813049},{"id":"https://openalex.org/keywords/histone-deacetylase-inhibitors","display_name":"histone deacetylase inhibitors","score":0.9269999861717224},{"id":"https://openalex.org/keywords/advanced-hematologic-malignancies","display_name":"advanced hematologic malignancies","score":0.9679999947547913},{"id":"https://openalex.org/keywords/acute-myeloid-leukemia","display_name":"acute myeloid leukemia","score":0.9390000104904175},{"id":"https://openalex.org/keywords/relapsed-refractory-aml","display_name":"relapsed/refractory AML","score":0.8100000023841858},{"id":"https://openalex.org/keywords/refractory-acute-lymphoblastic-leukemia","display_name":"refractory acute lymphoblastic leukemia","score":0.875},{"id":"https://openalex.org/keywords/myelodysplastic-syndrome","display_name":"myelodysplastic syndrome","score":0.9829999804496765},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8550000190734863},{"id":"https://openalex.org/keywords/qtc-prolongation","display_name":"QTc prolongation","score":0.9330000281333923},{"id":"https://openalex.org/keywords/sepsis","display_name":"sepsis","score":0.800000011920929},{"id":"https://openalex.org/keywords/histone-acetylation","display_name":"histone acetylation","score":0.8799999952316284},{"id":"https://openalex.org/keywords/p21","display_name":"p21","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8160364627838135},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5941780805587769},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.5728396773338318},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.5050473809242249},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4876369535923004},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.4716448187828064},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4438028633594513},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.22742509841918945},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v104.11.1802.1802","doi":"https://doi.org/10.1182/blood.v104.11.1802.1802","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v104.11.1802.1802","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.8500000238418579,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2104337841","https://openalex.org/W2247085032","https://openalex.org/W2965624578","https://openalex.org/W2564282262","https://openalex.org/W2258225306","https://openalex.org/W2589922185","https://openalex.org/W2052373315","https://openalex.org/W3173891460","https://openalex.org/W4250705761","https://openalex.org/W2589468392"],"abstract_inverted_index":{"Abstract":[0],"LBH589":[1,26,144,221,373,415],"is":[2],"a":[3,31,38,155,309,369],"novel":[4],"HDAC":[5],"inhibitor":[6],"which":[7],"activates":[8],"p21":[9],"and":[10,13,111,207,229,262,272,277,285,297,361,366,385,393,401,430],"inhibits":[11],"proliferation":[12,322],"induces":[14],"apoptosis":[15,313,341,351],"in":[16,175,223,225,259,287,306,312,327,340],"tumor":[17],"cell":[18,163],"lines":[19],"at":[20,79,108,113,129,182,421],"nanomolar":[21],"concentrations.":[22],"In":[23,210],"this":[24,304],"study,":[25],"was":[27,167,173,330,411],"administered":[28],"IV":[29,417],"as":[30,145,147,345],"30-minute":[32],"infusion":[33],"on":[34,140,291,342,358,406],"days":[35,359],"1\u20137":[36],"of":[37,118,133,202,212,256,282,350,363],"21":[39],"day":[40,242,343],"cycle.":[41],"Fourteen":[42],"pts.":[43],"(median":[44],"61":[45],"years":[46],"[range":[47],"42\u201387],":[48],"performance":[49],"status":[50],"0":[51],"(2":[52,61,93,215],"pts)":[53],"or":[54,318,321],"1":[55,190,360,365],"(12":[56],"pts),":[57,62,67,85,88,94],"de":[58],"novo":[59],"AML":[60,65,180],"relapsed":[63],"/refractory":[64],"(10":[66],"refractory":[68,179],"ALL":[69],"(1":[70,74,90],"pt),":[71,91],"MDS":[72],"(RAEB)":[73],"pt)":[75],"have":[76,103],"been":[77,104],"treated":[78,128,169,181],"dose":[80,384,404],"levels":[81,255,349,405],"(mg/m2):":[82],"4.8":[83],"(3":[84,87],"7.2":[86],"9.0":[89],"11.5":[92,114,424],"14.0":[95,109,130,183,402],"(5":[96],"pts).":[97],"Four":[98],"DLT\u2019s":[99],"(G3":[100],"QTcF":[101],"prolongation)":[102],"observed":[105,174],"\u2212":[106],"3":[107],"mg/m2":[110,115,131,425],"one":[112,176],"(a":[116],"total":[117],"357":[119],"ECG\u2019s":[120],"were":[121,153,217,266,356,375,389],"performed":[122],"during":[123,231,252],"the":[124,148,159,236,348],"study).":[125],"One":[126],"patient":[127,177],"died":[132],"pulmonary":[134],"hemmorhage":[135],"resulting":[136],"from":[137,293,298],"sepsis":[138],"while":[139],"study.":[141],"Treatment":[142],"with":[143,170,178,220,347,383,426],"well":[146,419],"patient\u2019s":[149],"underlying":[150],"disease":[151],"(MDS)":[152],"considered":[154],"contributing":[156],"factors":[157],"to":[158,250,295,300],"sepsis.":[160],"A":[161],"white":[162],"differentiation":[164],"syndrome":[165],"(which":[166],"sucessfully":[168],"high-dose":[171],"steroids)":[172],"mg/m2.":[184],"Other":[185],"LBH589-related":[186],"toxicities":[187],"included:":[188],"Grade":[189,196],"ST-T":[191],"wave":[192],"abnormality,":[193],"palpitations,":[194],"hypokalemia;":[195],"2":[197],"diarrhea,":[198],"nausea,":[199],"vomiting,":[200],"loss":[201],"appetite,":[203],"headache,":[204],"atrial":[205],"fibrillation,":[206],"QT":[208],"prolongation.":[209],"9":[211],"12":[213],"patients":[214,216],"aleukemic),":[218],"treatment":[219,238],"resulted":[222],"reductions":[224],"peripheral":[226,263,334],"blasts,":[227],"WBC":[228],"platelets":[230],"treatment.":[232,253],"Counts":[233],"rebounded":[234],"following":[235],"7-day":[237],"period":[239],"(generally":[240],"by":[241,315,324],"15).":[243],"Bone":[244],"marrow":[245,261],"blast":[246],"counts":[247],"generally":[248],"continued":[249],"increase":[251,305,339],"The":[254,279],"histone":[257,307],"acetylation":[258,281,308],"bone":[260],"blood":[264,335],"cells":[265,289,329],"measured":[267],"using":[268,368,377],"quantitative":[269],"flow":[270],"cytometry":[271],"antibodies":[273],"against":[274],"histones":[275,283],"H2B":[276,284],"H3.":[278],"median":[280],"H3":[286],"CD34+":[288,328],"increased":[290,381],"therapy":[292],"4463":[294],"17185":[296],"11540":[299],"66224,":[301],"respectively.":[302],"Despite":[303],"significant":[310,338],"change":[311],"(measured":[314,323],"annexin":[316],"V":[317],"mitochondrial":[319],"potential)":[320],"BrdU":[325],"incorporation)":[326],"not":[331],"demonstrated.":[332],"However,":[333],"lymphocytes":[336],"showed":[337],"7":[344,362],"compared":[346],"before":[352],"therapy.":[353],"PK":[354],"samples":[355],"collected":[357],"cycle":[364],"analyzed":[367],"noncompartmental":[370],"analysis.":[371],"Plasma":[372],"concentrations":[374],"determined":[376],"HPLC/MS/MS":[378],"assay.":[379],"AUC":[380],"proportionally":[382],"mean":[386],"AUCs":[387],"(0\u201324h)":[388],"139.47,":[390],"131.46,":[391],"189.12,":[392],"344.28":[394],"ng.h/mL,":[395],"respectively,":[396],"for":[397],"4.8,":[398],"7.2,":[399],"9.0,":[400],"mg/M2":[403],"Day":[407],"1.":[408],"Terminal":[409],"half-life":[410],"approximately":[412],"11":[413],"hrs.":[414],"given":[416],"appears":[418],"tolerated":[420],"doses":[422],"below":[423],"consistent":[427],"transient":[428],"antileukemic":[429],"PD":[431],"effects.":[432]},"counts_by_year":[],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2016-11-30T00:00:00"}